The upregulation of CD1C, CD40, CD80, and CD86 on Bregs shown in our study indicated that Bregs might exhibit a strong ability of antigen presentation in the MPE immune microenvironment in vivo due to tumor antigen stimulation. The gene discussed is CD1C; the disease is neoplasm.